Your browser doesn't support javascript.
loading
Challenges and Opportunities Associated With Platelets in Pancreatic Cancer.
Chen, Zhou; Wei, Xiaodong; Dong, Shi; Han, Fangfang; He, Ru; Zhou, Wence.
Afiliación
  • Chen Z; The First Clinical Medical College, Lanzhou University, Lanzhou, China.
  • Wei X; Department of General Surgery, The First Hospital of Lanzhou University, Lanzhou, China.
  • Dong S; Emergency Department, Gansu Provincial Hospital, Lanzhou, China.
  • Han F; Department of General Surgery, The First Hospital of Lanzhou University, Lanzhou, China.
  • He R; The First Clinical Medical College, Lanzhou University, Lanzhou, China.
  • Zhou W; Department of General Surgery, The First Hospital of Lanzhou University, Lanzhou, China.
Front Oncol ; 12: 850485, 2022.
Article en En | MEDLINE | ID: mdl-35494001
ABSTRACT
Pancreatic cancer is one of the most common malignant tumors in the digestive system with a poor prognosis. Accordingly, better understanding of the molecular mechanisms and innovative therapies are warranted to improve the prognosis of this patient population. In addition to playing a crucial role in coagulation, platelets reportedly contribute to the growth, invasion and metastasis of various tumors, including pancreatic cancer. This narrative review brings together currently available evidence on the impact of platelets on pancreatic cancer, including the platelet-related molecular mechanisms of cancer promotion, pancreatic cancer fibrosis, immune evasion, drug resistance mechanisms, thrombosis, targeted platelet therapy, combined radiotherapy and chemotherapy treatment, platelet combined with nanotechnology treatment and potential applications of pancreatic cancer organoids. A refined understanding of the role of platelets in pancreatic cancer provides the foothold for identifying new therapeutic targets.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: China